Your browser doesn't support javascript.
loading
Tolerability and pharmacokinetic evaluation of inhaled dry powder hydroxychloroquine in healthy volunteers.
de Reus, Y A; Hagedoorn, P; Sturkenboom, M G G; Grasmeijer, F; Bolhuis, M S; Sibum, I; Kerstjens, H A M; Frijlink, H W; Akkerman, O W.
Afiliação
  • de Reus YA; Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Hagedoorn P; Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, The Netherlands.
  • Sturkenboom MGG; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Grasmeijer F; Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, The Netherlands.
  • Bolhuis MS; PureIMS B.V., Roden, The Netherlands.
  • Sibum I; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Kerstjens HAM; Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, The Netherlands.
  • Frijlink HW; Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Akkerman OW; Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, The Netherlands.
PLoS One ; 17(8): e0272034, 2022.
Article em En | MEDLINE | ID: mdl-35930536
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 / Hidroxicloroquina Limite: Humans Idioma: En Revista: PLoS One Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 / Hidroxicloroquina Limite: Humans Idioma: En Revista: PLoS One Ano de publicação: 2022 Tipo de documento: Article